UBS has downgraded its stance on global equities from attractive to neutral in its 2027 outlook. The bank argues that following a prolonged period of growth, the potential rewards for investors are now more evenly balanced against the risks. This shift places UBS in direct opposition to Morgan Stanley, which recently moved to a maximum overweight position on global stocks.
Despite the downgrade, UBS maintains a constructive view on corporate earnings. It notes that global economic growth remains near trend levels and that demand for computing power continues to drive investment in artificial intelligence. However, the bank warns that current market valuations leave little room for error. A significant concern is index concentration, with the ten largest companies in the S&P 500 now accounting for 39% of the index. UBS suggests that elevated expectations and uncertainty regarding the AI investment cycle could lead to lower earnings multiples if inflation remains persistent or bond yields stay high.
In terms of asset allocation, UBS currently favours bonds and commodities over equities, while cash remains its least preferred asset. Within fixed income, the bank sees potential in emerging market and high-yield debt. For equity investors, the firm recommends a shift in strategy rather than a full exit. It highlights the Eurozone as a preferred market, projecting 15% earnings growth for 2027, and suggests focusing on industrials and health care. The bank advocates for equal-weight US strategies to mitigate the risks associated with highly concentrated technology holdings.